- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06864754
WashU DIEP Flap Video and Patient Understanding Improvement
Patients will complete a survey before and after watching the WashU DIEP Flap Video at their pre-operative standard of care visit, and a third survey at their post-operative standard of care visit. These surveys will use questions from SILS, APAIS, PEMAT, and AIM/IAM to assess the patient's health literacy, demographics questions, and questions concerning patient understanding and anxiety surrounding the procedure. The purpose of the post-op survey will be to assess how well the video set expectations of the procedure and recovery process and will repeat questions asked pre-operatively. Survey responses will be analyzed to determine if there are beneficial trends and improvement in patient understanding and anxiety due to adjunct video usage.
Primary Objective: The primary aim of the study is to determine if our animated video affects understanding and anxiety survey scores in patients undergoing DIEP breast reconstruction.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Justin M Sacks, M.D., MBA, FACS
- Phone Number: 314-362-7388
- Email: jmsacks@wustl.edu
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Contact:
- Justin M Sacks, M.D., MBA, FACS
- Phone Number: 314-362-7388
- Email: jmsacks@wustl.edu
-
Principal Investigator:
- Justin M Sacks, M.D., MBA, FACS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Scheduled to have DIEP-flap breast reconstruction at Barnes Jewish Hospital
- Speak English
- ≥ 18 years of age
Exclusion Criteria:
- Non-English speaking are excluded as the consent, questionnaires, and video are only available in English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: WashU DIEP Flap Video
At the pre-operative appointment, patients will complete the pre-video survey (~10min) via RedCap, watch the video (~5min), and complete the post-video survey (~10min) via RedCap.
During the standard of care follow-up appointment ≤ 30 days after surgery, consented patients will fill out a third survey via RedCap (~5min).
|
Video uses visual cues and graphics to help explain complex procedures in a simplified, comprehensible fashion to patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in understanding as measured by the Comprehension Assessment
Time Frame: Before video at pre-operative visit, after video at pre-operative visit, and at post-operative visit (estimated to be 3 months)
|
The pre-op, pre-video survey includes a 10-question comprehension assessment.
The pre-op, post-video survey repeats the comprehension assessment.
Scores of the comprehension assessment will be compared before and after video watching per patient to determine change in understanding due to the video.
It will be scored on a 10-point scale based on correct answers with a higher score meaning greater understanding of the procedure.
|
Before video at pre-operative visit, after video at pre-operative visit, and at post-operative visit (estimated to be 3 months)
|
|
Change in anxiety as measured by the Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: Before video at pre-operative visit, after video at pre-operative visit, and at post-operative visit (estimated to be 3 months)
|
Scores of the APAIS will be compared before and after video watching per patient to determine change in anxiety due to the video.
Scoring of APAIS will be per the literature (6-30 with higher score meaning greater anxiety).
|
Before video at pre-operative visit, after video at pre-operative visit, and at post-operative visit (estimated to be 3 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appropriate expectation setting as measured by The Patient Education Materials Assessment Tool (PEMAT)
Time Frame: Before video at pre-operative visit and at post-operative visit (estimated to be 3 months)
|
Will be used to assess video quality.
Validated scoring will be used (0-12 with higher score meaning better quality).
|
Before video at pre-operative visit and at post-operative visit (estimated to be 3 months)
|
|
Appropriate expectation setting as measured by the Acceptability of Intervention Measure (AIM)
Time Frame: At post-operative visit (estimated to be at 3 months)
|
Validated survey which will be used per published scoring guidelines (8-40 with higher score meaning greater acceptability.
|
At post-operative visit (estimated to be at 3 months)
|
|
Appropriate expectation setting as measured by the Intervention Appropriateness Measure (IAM)
Time Frame: At post-operative visit (estimated to be at 3 months)
|
Validated survey which will be used per published scoring guidelines (8-40 with higher score meaning greater appropriateness.
|
At post-operative visit (estimated to be at 3 months)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Justin M Sacks, M.D., MBA, FACS, Washington University School of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202503134
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on WashU DIEP Flap Video
-
Johns Hopkins UniversityAxogen CorporationTerminatedBreast Cancer | Breast Reconstruction | Sensory RestorationUnited States
-
Aalborg University HospitalCompletedBreast Neoplasms | Intraabdominal HypertensionDenmark
-
Vastra Gotaland RegionGöteborg UniversityRecruiting
-
University of ManitobaKeeping Abreast CharityCompletedDIEP Flap Breast Reconstruction | SIEA Flap Breast ReconstructionCanada
-
Vastra Gotaland RegionCompletedBreast CancerSweden
-
Assistance Publique - Hôpitaux de ParisINSERM Bichat hospitalCompleted
-
The National Institute of LymphologyThe DrMarga Practice Group; The Center for Restorative Breast Surgery, LLCUnknownBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | Congenital Lymphedema | Acquired LymphedemaUnited States
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruiting
-
University of Colorado, DenverTerminatedPregnancy | IUGRUnited States
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingBreast Cancer | Postsurgical Acquired Absence of OrganRussian Federation